ANTX AN2 Therapeutics, Inc.: institutional ownership and insider trading
70 funds reported holding $120M of AN2 Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $13.0M, with 28 new positions and 14 funds selling out; over the last 12 months insiders bought $11.6K and sold $398K on the open market.
Famous investors holding ANTX
- Izzy Englander (Millennium Management): $11.2M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.61M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $628K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $77.0K, 0.0% of the portfolio
Largest institutional holders of ANTX
- Vivo Capital, LLC — $15.3M
- Commodore Capital LP — $14.2M
- MILLENNIUM MANAGEMENT LLC — $11.2M
- BlackRock, Inc. (BLK) — $8.06M
- Spruce Street Capital LP — $8.04M
- Almitas Capital LLC — $7.11M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.00M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $4.84M
- CITADEL ADVISORS LLC — $4.61M
- Boxer Capital Management, LLC — $3.63M
Recent ANTX insider trades
- Sep 9, 2026: Readnour Robin Shane sold 1,108 shares ($6.67K)
- Sep 8, 2026: Readnour Robin Shane sold 16,119 shares ($97.3K)
- Sep 1, 2026: Williams Sarah Joanne sold 272 shares ($1.50K)
- Sep 1, 2026: FitzPatrick Margaret M bought 2,098 shares ($11.6K)
5%+ owners
- Commodore Capital LP: 9.9% (Schedule 13G, filed Mar 16, 2026)